Evidence map›Paper›PMID 40456280›Full record

SynthesisJornal de pediatria

Alternative antibiotics for the treatment of bacterial meningitis in children: a systematic review of efficacy and safety.

Ana Clara Valente de Alencar, Athus Graziani Apollaro Rego, Carolina Soares Chady, Alisson Gabriel Maués Miranda, Lara Fernanda Alves de Souza, João Vitor Martins Pinto, Bárbara de Souza Maia do Nascimento, Camili Giseli Oliveira de Menezes, Isa Mendes Moreira, José Carlos Favacho Furlan and 7 more

Abstract readSystematic Review
In one paragraph

Synthesis in Jornal de pediatria. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ana Clara Valente de AlencarCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Athus Graziani Apollaro RegoCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Carolina Soares ChadyCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Alisson Gabriel Maués MirandaCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Lara Fernanda Alves de SouzaCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
João Vitor Martins PintoCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Bárbara de Souza Maia do NascimentoCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Camili Giseli Oliveira de MenezesCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Isa Mendes MoreiraCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
José Carlos Favacho FurlanCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Ester Carolina Vieira MaiaCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Maria Fernanda Nakayama MartinsCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Nayara Cristina Cardoso da SilvaCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Paula do Socorro de Oliveira da Costa LaurindoCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil.
Luis Edilson de Azevedo FerreiraCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil; Universidade Federal do Pará (UFPA), Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Belém, PA, Brazil.
Antônio Rafael Quadros GomesUniversidade do Estado do Pará (UEPA), Centro de Ciências Biológicas e da Saúde (CCBS), Tucuruí, PA, Brazil; Universidade Federal do Pará (UFPA), Programa de Pós-Graduação em Biodiversidade e Biotecnologia (BIONORTE), Belém, PA, Brazil.
Heliton Patrick Cordovil BrígidoCentro Universitário Metropolitano da Amazônia (UNIFAMAZ), Curso de Medicina, Belém, PA, Brazil; Universidade Federal do Pará (UFPA), Programa de Pós-Graduação em Biodiversidade e Biotecnologia (BIONORTE), Belém, PA, Brazil; Universidade Federal do Pará (UFPA), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Belém, PA, Brazil. Electronic address: helitombrigido@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis systematic review aimed to evaluate the efficacy and safety of alternative antibiotics and different standard treatment regimens for bacterial meningitis in children, considering the increasing antimicrobial resistance and the need for adapted therapeutic options. To justify the use of alternative antibiotics, the authors analyzed the specific efficacy of ampicillin, chloramphenicol, cefuroxime and meropenem, which showed potential to overcome cases of antimicrobial resistance. DATA SOURCES: A search was performed in databases such as PubMed, Scopus, Web of Science and Cochrane Library, without data restrictions, including planned clinical trials that compared alternative antibiotics and different standard treatment regimens, such as ceftriaxone, in children with bacterial meningitis. Inclusion criteria include studies reporting cure rates, complications and safety of treatments. SUMMARY OF

resultsAn analysis of 14 studies, totaling 2,014 children, indicated that antibiotics such as ampicillin, chloramphenicol, cefuroxime and meropenem had comparable efficacy and safety to standard treatment regimens. The review showed that, in many cases, alternative regimens and shorter treatment durations could be effective, without significantly increasing complications or mortality.

conclusionThe results suggest that alternatives to standard treatment, such as ampicillin, chloramphenicol, cefuroxime and meropenem, are viable and safe options for the treatment of bacterial meningitis in children. These results help to adapt clinical practices, especially in settings with high antimicrobial resistance and resource limitations, by providing evidence for shorter and equally effective treatment regimens.

Indexed as

Anti-Bacterial AgentsMeningitis, BacterialAmpicillinCefuroximeChildChloramphenicolHumansMeropenemTreatment OutcomeAmpicillinAnti-Bacterial AgentsCefuroximeChloramphenicolMeropenemAntibioticsAntibiotic safetyBacterial meningitisCeftriaxoneClinical efficacy

Identifiers

PMID40456280
PMCPMC12744663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.